TOHOKU CHEMICAL CO., LTD. (7446) Stock Price

Tohoku Chemical Pharmaceuticals operates primarily through the sale of industrial chemicals, clinical diagnostic reagents, food and agricultural products, and related equipment. The company also provides equipment maintenance and related services. By offering comprehensive support from product supply through maintenance, the company delivers customized solutions tailored to customer needs.

The company serves a diverse customer base including manufacturers in chemicals, semiconductors, and food production, as well as hospitals, diagnostic centers, universities, research institutions, and agricultural businesses. Revenue is primarily driven by product sales, with regular purchases of reagents and consumables providing stable income. Equipment sales generate initial revenue upon installation, followed by ongoing revenue from maintenance and consumable supplies.

The company's business is divided into three segments: "Industry," "Medical," and "Academia & Life Sciences." The Industry segment handles industrial chemicals, analytical and measurement equipment, and food ingredients. The Medical segment provides diagnostic reagents, medical devices, and consumables. The Academia & Life Sciences segment supplies research reagents, antibody reagents, and analytical equipment.

Based on its medium-term management plan, the company aims for steady growth and strengthened profitability. Specifically, it targets sales of 35 billion yen (up 1.6% year-over-year), operating profit of 5.3 billion yen (up 2.3%), ordinary profit of 6.2 billion yen (up 4.2%), and net profit attributable to parent company shareholders of 4.3 billion yen (up 0.3%). The company ensures alignment between short-term and medium-term goals through annual plan updates. It prioritizes eliminating waste and inefficiency and improving labor productivity to establish a stable earnings foundation.

The company identifies consumables and reagents that generate recurring revenue, as well as equipment maintenance and service operations, as key investment areas. This approach aims to stabilize earnings not only from initial equipment sales but also through maintenance contracts and regular consumables sales. The company seeks to expand gross margins by diversifying suppliers and strengthening proposal capabilities. It differentiates itself through close collaboration with customers (headwork), quick delivery and responsiveness (footwork), and an extensive business network (network).

To develop new markets and expand operations, the company strengthens cross-selling among its existing Industrial, Medical, and Academia & Life Sciences divisions while expanding proposals into high-demand sectors including semiconductors, food, medical institutions, and agriculture. It pursues new business development and cultivation, and will use strategic partnerships and selective acquisitions as needed to supplement sales channels and technology. Regionally, the company prioritizes strengthening domestic coverage first and will consider selective overseas expansion based on profitability assessments.

The company also invests in technological innovation, advancing digitalization and labor-saving measures to enhance service quality. Specific initiatives include remote equipment monitoring, preventive maintenance systems, automated inspection support, and customer information platforms—all aimed at improving maintenance efficiency and customer satisfaction. Additionally, the company strengthens technological advantages through collaborative research with universities and research institutions and in-house reagent development. It also promotes SDGs alignment and internal control enhancement to increase corporate value.